Send your comments and tips to firstname.lastname@example.org
Beth Israel Deaconess Medical Ctr.
Boston Medical Center
Brigham and Women's Hospital
Cambridge Health Alliance
Caritas St. Elizabeth's Medical Ctr.
Children's Hospital Boston
Dana-Farber Cancer Institute
Joslin Diabetes Center
Mass. General Hospital
Mass. Health Law
New England Baptist Hospital
Short White Coat
Tufts-New England Medical Center
UMass Memorial Medical Center
University of Massachusetts
VA Medical Centers
A Healthy Blog
Running A Hospital
Nature Network Boston
SciBos - Corie Lok's blog
Nurse at small
Dr. Gwenn Is In
Healthy Children blog
Other Globe Blogs
Elizabeth Cooney is a health reporter for the Worcester Telegram & Gazette.
Boston Globe Health and Science staff:
Karen Weintraub, Deputy Health and Science Editor, and Gideon Gil, Health and Science Editor.
Short White Coat blogger Ishani Ganguli
Short White Coat blogger Jennifer Srygley
Friday, August 24, 2007
Today's Globe: health insurance suit, out-of-body experience, disease travel, sunscreen, flu shots, Dr. James Melby
Attorney General Martha Coakley yesterday filed a revised complaint against a group of health insurance companies stating that the firms denied policyholders benefits required by law, disclosed confidential patient information, and used unfair and deceptive sales practices.
Using virtual reality goggles, a camera, and a stick, scientists have induced out-of-body experiences -- the sensation of drifting outside one's body -- in healthy people, according to experiments being published in the journal Science.
New infectious diseases are emerging at an "unprecedented rate," and far greater human mobility -- by planes, trains, and ships -- means that infectious diseases have the potential to spread across the globe rapidly, a World Health Organization report warned yesterday.
Sun lotions should be required to carry new ratings letting consumers compare for the first time how well the products guard against a form of skin-damaging ultraviolet rays, US regulators said.
GlaxoSmithKline PLC and Novartis AG, two of the world's biggest vaccine makers, may have bet on the wrong technology in the race to develop a better flu shot. The drug makers are building US factories to grow influenza virus in animal cells as an advance over the decades-old technique of using chicken eggs. Now a small, privately held biotechnology company may leapfrog ahead of them with a more advanced method using DNA.